Nordson Corporation (NDSN) has been involved in vast financial and strategic activities. The company has resorted to
M&A amidst stagnating
organic growth, thereby making major headway into the medical industry with the
acquisition of
Atrion Corporation. Despite some insider selling indicating possible caution, institutional investors show strong interest in NDSN, owning roughly
75% of the company. Shares are also increasingly being acquired by various financial institutions like
Boston Trust Walden Corp and
Copeland Capital Management. In the midst of these developments, however, there is news of a
layoff in NDSN's Amherst operations, moving work to South Carolina and
reducing sales and earnings guidance. Q3 earnings beat estimates, signalling positive growth accomplished through strategic initiatives, including a higher
dividend announcement and
rating upgrade to buy. Yet some experts argue the rate of capital deployment does not match the current valuations, indicating potential overvaluation. Despite recent challenges, those who invested in Nordson five years back have seen their investment increase 81%.
Nordson Corp NDSN News Analytics from Mon, 04 Aug 2014 07:00:00 GMT to Sat, 26 Oct 2024 16:35:49 GMT -
Rating 2
- Innovation 0
- Information 8
- Rumor -4
